Description:

Southwest Oncology Group Registration Form (S0226) S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer NCT00075764 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C3225DE6-8BA0-26CF-E034-0003BA12F5E7

Lien:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C3225DE6-8BA0-26CF-E034-0003BA12F5E7
Mots-clés:
  1. 26/08/2012 26/08/2012 -
  2. 24/04/2015 24/04/2015 - Martin Dugas
  3. 27/09/2021 27/09/2021 -
Téléchargé le:

27 septembre 2021

DOI:
Pour une demande vous connecter.
Licence :
Creative Commons BY-NC 3.0 Legacy
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Breast Cancer Registration SWOG S0226 NCT00075764

No Instruction available.

  1. StudyEvent: Southwest Oncology Group Registration Form (S0226)
    1. No Instruction available.
Header
Method of Payment
Patient data
Patient Gender
Patient's Ethnicity
Patient's Race
Prior adjuvant tamoxifen therapy
Consent
My tissue may be kept for use in research to learn about, prevent, treat, or cure cancer.
My tissue may be kept for research about other health problems
Someone from Southwest Oncology Group may contact me in the future to ask me to take part in more research
I agree to allow my study doctor, or someone approved by my study doctor, to contact me regard future research involving my participation in this study
I agree to submit blood samples for the purpose of determining how my body metabolizes the drugs, fulvestrant and anastrozole
I agree to submit blood samples for the analysis of human epidermal growth factor receptor 2 (HER-2) protein to see if high levels will predict if I am less likely to respond to hormone therapy
I agree to submit a blood specimen for genetic expression studies to study what role the protocol treatment is having on my disease
I agree to submit a tissue specimen for the analysis of estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER-2) to see if certain levels will predict if I am likely to respond to hormone therapy

Similar models

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial